Cargando…

Whole-transcriptome sequencing identified gene expression signatures associated with aggressive clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of kidney cancer, yet molecular biomarkers have not been used for the prognosis of ccRCC to aide clinical decision making. This study aimed to identify genes associated with ccRCC aggressiveness and overall survival (OS). Samples...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batai, Ken, Imler, Elliot, Pangilinan, Jayce, Bell, Robert, Lwin, Aye, Price, Elinora, Milinic, Tijana, Arora, Amit, Ellis, Nathan A., Bracamonte, Erika, Seligmann, Bruce, Lee, Benjamin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305109/ https://www.ncbi.nlm.nih.gov/pubmed/30603059 http://dx.doi.org/10.18632/genesandcancer.183

Ejemplares similares

Correlation between body mass index and prostate volume in benign prostatic hyperplasia patients undergoing holmium enucleation of the prostate surgery
por: Batai, Ken, et al.
Publicado: (2021)

Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients
por: Batai, Ken, et al.
Publicado: (2023)

Investigation of confocal microscopy for differentiation of renal cell carcinoma versus benign tissue. Can an optical biopsy be performed?
por: Phung, Michael C., et al.
Publicado: (2020)

Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK)
por: Fiore, Michele, et al.
Publicado: (2023)

A 28-Year-Old Man With Chest Pain, Shortness of Breath, and Hemoptysis After Recovery From Coronavirus Disease 2019 Pneumonia
por: Odackal, John, et al.
Publicado: (2021)

The Notch and TGF-β Signaling Pathways Contribute to the Aggressiveness of Clear Cell Renal Cell Carcinoma
por: Sjölund, Jonas, et al.
Publicado: (2011)

Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma
por: Sitaram, Raviprakash T., et al.
Publicado: (2016)

Cellular and physical microenvironments regulate the aggressiveness and sunitinib chemosensitivity of clear cell renal cell carcinoma
por: Nagase, Kei, et al.
Publicado: (2021)

Cutaneous Clear Cell Sarcoma: A Rare Aggressive Tumor with Potential Diagnostic Challenge
por: Bali, Akshay, et al.
Publicado: (2012)

Clear cell tumor of the lung could be aggressive: a case report and review of the literature
por: Shen, Leilei, et al.
Publicado: (2020)

Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration
por: Zhang, Chiyu, et al.
Publicado: (2023)

The Case of an Obstructed Stone at the Distal Urethra
por: Higa, Kelcy, et al.
Publicado: (2017)

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma
por: Eichenauer, Till, et al.
Publicado: (2020)

Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels
por: Esser, Laura Kristin, et al.
Publicado: (2022)

Extraction-free whole transcriptome gene expression analysis of FFPE sections and histology-directed subareas of tissue
por: Trejo, Christy L., et al.
Publicado: (2019)

Differential expression of microRNA501-5p affects the aggressiveness of clear cell renal carcinoma
por: Mangolini, Alessandra, et al.
Publicado: (2014)

MicroRNA-375 Suppresses the Tumor Aggressive Phenotypes of Clear Cell Renal Cell Carcinomas through Regulating YWHAZ
por: Zhang, Xiang, et al.
Publicado: (2018)

Prognostic Value of Vascular Endothelial Growth Factor A in the Prediction of the Tumor Aggressiveness in Clear Cell Renal Cell Carcinoma
por: Veselaj, Fahredin, et al.
Publicado: (2017)

High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10
por: Ma, Wenliang, et al.
Publicado: (2022)

Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men
por: Nelson, Shakira M., et al.
Publicado: (2016)

Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
por: Vecchio, Sharon J. Del, et al.
Publicado: (2018)

Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
por: Arai, Eri, et al.
Publicado: (2015)

Risk Prediction Tool for Aggressive Tumors in Clinical T1 Stage Clear Cell Renal Cell Carcinoma Using Molecular Biomarkers
por: Park, Jee Soo, et al.
Publicado: (2019)

High expression of F2RL3 correlates with aggressive features and poor survival in clear cell renal cell carcinoma
por: Cao, Dalong, et al.
Publicado: (2018)

8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2020)

Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type
por: Cai, Qi, et al.
Publicado: (2019)

MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas
por: Wang, Michelle Y., et al.
Publicado: (2021)

Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers
por: Park, Jee Soo, et al.
Publicado: (2020)

Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas
por: Gao, Jing, et al.
Publicado: (2021)

Therapeutic Applications of Programmable DNA Nanostructures
por: Aye, Seaim Lwin, et al.
Publicado: (2022)

Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients
por: Fabbri, Lucilla, et al.
Publicado: (2020)

STAT3 phosphorylation at serine 727 activates specific genetic programs and promotes clear cell renal cell carcinoma (ccRCC) aggressiveness
por: Arévalo, J., et al.
Publicado: (2023)

Increasing trends in admissions due to non-communicable diseases over 2012 to 2017: findings from three large cities in Myanmar
por: Swe, Ei Ei, et al.
Publicado: (2020)

Transplant Programs in APBMT: Blood and Marrow Transplant Activity Report from Myanmar APBMT Meeting 2018, Taiwan
por: Gyi, Aye Aye, et al.
Publicado: (2019)

Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
por: Doppalapudi, Sai Krishnaraya, et al.
Publicado: (2021)

Response to Stutz et al. re: “Management of Suspected Bladder Injury and Capsular Perforation After Holmium Laser Enucleation of the Prostate”
por: Lwin, Aye, et al.
Publicado: (2018)

Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma
por: D’Costa, Ninadh M., et al.
Publicado: (2020)

HyClear: A Novel Tissue Clearing Solution for One-Step Clearing of Microtissues
por: Nasseri, S. Soroush, et al.
Publicado: (2022)

'Salvage Treatment' of Aggressive Giant Cell Tumor of Bones with Denosumab
por: Vaishya, Raju, et al.
Publicado: (2015)

Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
por: Arai, Eri, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9umj596o7hvgpvfui04k517teu